EMA — authorised 4 May 2023
- Marketing authorisation holder: CHIESI FARMACEUTICI S.P.A
- Status: approved
🇪🇺 Elfabrio in European Union
EMA authorised Elfabrio on 4 May 2023
Marketing authorisation
Elfabrio in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in European Union
Frequently asked questions
Is Elfabrio approved in European Union?
Yes. EMA authorised it on 4 May 2023.
Who is the marketing authorisation holder for Elfabrio in European Union?
CHIESI FARMACEUTICI S.P.A holds the EU marketing authorisation.